https://www.biospace.com/bristol-myers-squibb-presents-updated-efficacy-data-from-phase-2-trial-of-empliciti-elotuzumab-plus-pomalidomide-and-dexamethasone-in-patients-with-relapsed-or-refractory-multiple-myeloma-rrmm
Bristol-Myers Squibb Company announced the presentation of updated data from ELOQUENT-3, the international randomized Phase 2 study evaluating Empliciti plus...
bristol myers squibbpresentsupdatedefficacydata
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/elotuzumab
NCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine.
definitionelotuzumabncidictionarycancer